Factors associated with the severity of premenstrual symptoms in women with central obesity: a cross-sectional study

• Main Authors: Payam Sharifan (Author), Ali Jafarzadeh Esfehani (Author), Amir Zamiri (Author), Mansoureh Sadat Ekhteraee Toosi (Author), Fatemeh Najar Sedgh Doust (Author), Niloufar Taghizadeh (Author), Maryam Mohammadi-Bajgiran (Author), Hamideh Ghazizadeh (Author), Fatemeh Khorram Rouz (Author), Gordon Ferns (Author), Majid Ghayour-Mobarhan (Author)
• Format: Book
• Published: BMC, 2023-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 10.1186/s41043-022-00343-5; 2072-1315
• Keywords: Premenstrual syndrome; Risk factors; Nutritional status; Depression; Psychometrics; Nutritional diseases. Deficiency diseases; RC620-627; Public aspects of medicine; RA1-1270
• Source: Journal of Health, Population and Nutrition, Vol 42, Iss 1, Pp 1-9 (2023)

Abstract Introduction Premenstrual syndrome (PMS) is a common condition that affects social and psychological well-being of women. The risk of PMS is higher among obese women. The aim of this study was to identify the factors that influence the severity of PMS in women with central obesity. Materials and methods This cross-sectional study was performed on 30-50 year-old women with abdominal obesity (waist circumference > 80 cm). The following data were collected: demographic data, anthropometric measurements, premenstrual symptoms screening tools, semi-quantitative food frequency questionnaire, 42-item depression, anxiety, and stress questionnaire (DASS-42), as well as serum vitamin D, and renal function tests. Results A total of 139 women (mean age of 41.40 ± 7.39 years old) participated in the study. The prevalence of mild, moderate and severe premenstrual symptoms was 38.7% (55/142), 31.7% (45/142) and 27.5% (39/142), respectively. There was no significant difference between the groups in terms of anthropometric measurements and energy-adjusted nutrient intakes (p > 0.05). There was a significant relationship between moderate PMS and energy-adjusted saturated fatty acid (SFA) (p = .018, OR = .010 and 95% CI for OR: < .001 and .452), and energy-adjusted riboflavin (p = .042, OR = .005, 95% CI for OR: < .001 and .821), and between severe PMS and age (p = .034, OR = .906, 95% CI for OR: .826 and .993), and energy-adjusted monounsaturated fatty acid (MUFA) intake (p = .041, OR = 23.789, 95% CI for OR: 1.138 and 497.294). Conclusion High intakes of MUFA and younger age were associated with a greater severity of PMS, while riboflavin intake was associated with reduced PMS severity.